• CARMIL Membrane-Binding Domain: Mechanisms Regulating Actin

  2026-04-20

  This study uncovers the multifaceted biochemical functions of the membrane-binding (MB) domain of CARMIL, demonstrating its essential role in actin filament regulation. By elucidating how the MB domain coordinates actin capping protein activity and membrane association, the findings provide mechanistic insight into membrane-driven actin assembly processes.

• Phenothiazines Induce Macrophage Antibacterial Activity via

  2026-04-20

  This study demonstrates that phenothiazine compounds, including promethazine hydrochloride, significantly enhance the antibacterial function of macrophages by triggering reactive oxygen species (ROS) generation and autophagy. These findings highlight host-directed therapy as a promising approach to address antibiotic resistance in intracellular bacterial infections.

• Bismuth Subsalicylate: Workflow Parameters & GI Disorder Res

  2026-04-19

  Bismuth Subsalicylate (SKU A8382) addresses reproducibility and selectivity challenges in gastrointestinal disorder research, particularly where precise Prostaglandin G/H Synthase 1/2 inhibition is required. It is not suitable for diagnostic or clinical applications and should be handled according to strict research-use protocols.

• Sodium Dicloxacillin Monohydrate: Optimizing MSSA Infection

  2026-04-18

  Sodium dicloxacillin monohydrate empowers researchers to dissect methicillin-sensitive Staphylococcus aureus (MSSA) pathogenesis with precision, bridging in vitro and in vivo experimental workflows. This article translates landmark reference findings and APExBIO’s technical expertise into actionable protocols and troubleshooting strategies for high-impact Gram-positive infection research.

• Salinomycin as a Precision Tool in HCC Research: Mechanistic

  2026-04-17

  Explore how Salinomycin, a polyether ionophore antibiotic, is redefining hepatocellular carcinoma research with advanced mechanistic insights and evidence-driven protocol design. This article uniquely bridges molecular pharmacology with practical lab application, setting it apart from existing content.

• 5-hme-dCTP: Precision for Epigenetic DNA Modification Resear

  2026-04-16

  5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate) empowers researchers to map and manipulate 5-hydroxymethylcytosine with single-base resolution in plant and mammalian systems. APExBIO’s high-purity reagent streamlines workflows in DNA hydroxymethylation assays, gene regulation studies, and plant drought response epigenetics—delivering reproducibility and sensitivity where it matters most.

• Viral-Induced Degradation of RIPK3 Regulates Inflammation

  2026-04-15

  Liu et al. identify a class of orthopoxvirus proteins that target the necroptosis adaptor kinase RIPK3 for proteasomal degradation, thereby modulating virus-induced inflammation and host response. This mechanistic insight informs both viral pathogenesis research and strategies for dissecting regulated cell death pathways in infection models.

• Aztreonam: Mechanistic Innovation and Translational Strategy

  2026-04-14

  This thought-leadership article explores Aztreonam—APExBIO’s synthetic monocyclic β-lactam antibiotic—through the lens of escalating Gram-negative multidrug resistance. Fusing mechanistic depth, experimental insights, and strategic guidance, it offers translational researchers a rigorous roadmap for leveraging Aztreonam in the study of antibiotic activity, bone marrow inhibition, and cytochrome P450 modulation. Anchored by recent epidemiological findings from Guangdong, China, and integrating the latest in product intelligence, the discussion contextualizes Aztreonam’s unique research utility against the competitive landscape and articulates a forward-looking vision for translational workflows.

• EdU Imaging Kits (Cy3): Precision S-Phase Detection in Proli

  2026-04-13

  EdU Imaging Kits (Cy3) empower researchers to quantify cell proliferation with unmatched sensitivity and simplicity, harnessing click chemistry for direct S-phase analysis. This workflow-centric guide details how to optimize experimental design and troubleshoot challenges, with insights anchored in recent cancer research and APExBIO reliability.

• DiscoveryProbe™ Metabolism-related Compound Library: Technic

  2026-04-12

  The DiscoveryProbe™ Metabolism-related Compound Library (SKU L1032) provides a rigorously validated, ready-to-use panel of 493 metabolism-related compounds for high-throughput metabolic pathway research. It is best suited for in vitro and ex vivo applications requiring precise, reproducible modulation of metabolic enzymes or pathways. This product is not intended for diagnostic or clinical use, and its utility is bounded by the specificity and stability parameters defined in the manufacturer’s documentation.

• Re-evaluating ACE Inhibitors: Specificity Toward Aminopeptid

  2026-04-12

  This study systematically compares how various metallopeptidase inhibitors, including those targeting angiotensin converting enzyme (ACE), interact with aminopeptidases N, A, and W on mammalian cell surfaces. The findings clarify the selectivity profiles of classic inhibitors, with implications for research in hypertension, cardiovascular, and renal disease models.

• Azathramycin A: Macrolide Antibiotic Workflows for TB Models

  2026-04-11

  Azathramycin A empowers researchers to dissect protein synthesis inhibition in Mycobacterium tuberculosis with unmatched specificity. This guide delivers actionable workflow enhancements, comparative advantages, and troubleshooting insights for antibacterial agent development and resistance modeling.

• AO/PI Staining Solution: Precision in Fluorescent Cell Viabi

  2026-04-11

  AO/PI Staining Solution delivers unmatched accuracy in live/dead cell discrimination, outperforming traditional viability stains and minimizing interference from impurities or red blood cells. Explore its stepwise workflow, optimization, and troubleshooting for advanced fluorescence-based cell counting in complex disease models.

• Aztreonam: Unveiling Mechanistic Insights and Research Fr...

  2026-04-10

  Explore how Aztreonam, a synthetic monocyclic β-lactam antibiotic, drives innovation in Gram-negative bacterial infection research and drug metabolism studies. This article uniquely analyzes Aztreonam's molecular impact on resistance mechanisms, bone marrow toxicity, and cytochrome P450 modulation.

• Cefodizime: Mechanisms, Pharmacodynamics, and Next-Gen In...

  2026-04-09

  Explore Cefodizime, a third-generation cephalosporin antibiotic, through a rigorous analysis of its molecular action, immunomodulatory properties, and advanced applications in microbiology research. This article uniquely dissects its pharmacodynamics, resistance implications, and innovation potential for infectious disease models.

452 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page